Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling

Endocrinology

Volumn 146, Issue 3, 2005, Pages 1498-1505

  Laviola, Luigi ^a   Perrini, Sebastio ^a   Belsanti, Gaetana ^a   Natalicchio, Annalisa ^a   Montrone, Carmela ^a   Leonardini, Anna ^a   Vimercati, Antonella ^a   Scioscia, Marco ^a   Selvaggi, Luigi ^a   Giorgino, Riccardo ^a   Greco, Pantaleo ^b   Giorgino, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SHC; RECEPTOR PROTEIN; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BIRTH WEIGHT; BODY WEIGHT; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; FETAL GROWTH RETARDATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; ORGAN SIZE; PHOSPHOPROTEINS; PHOSPHORYLATION; PLACENTA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 20044376471     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1332     Document Type: Article

References (63)

1. Resnik R 2002 Intrauterine growth restriction. Obstet Gynecol 99:490-496
2. Seeds JW 1984 Impaired fetal growth: definition and clinical diagnosis. Obstet Gynecol 64:303-310
3. Hattersley AT, Tooke JE 1999 The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 353:1789-1792
4. Baschat AA, Weiner CP 2000 Umbilical artery doppler screening for detection of the small fetus in need of antepartum surveillance. Am J Obstet Gynecol 182:154-158
5. Khong TY, De Wolf F, Robertson WB, Brosens I 1986 Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93:1049-1059
6. Fowden AL 2003 The insulin-like growth factors and feto-placental growth. Placenta 24:803-812
7. LeRoith D, Werner H, Beitner-Johnson D, Roberts C 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143-163
8. Vincent AM, Feldman EL 2002 Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12:193-197
9. Holmes RP, Holly JM, Soothill PW 1998 A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses. Br J Obstet Gynaecol 105:1273-1278
10. Abu-Amero SN, Ali Z, Bennett P, Vaughan JI, Moore GE 1998 Expression of the insulin-like growth factors and their receptors in term placentae: a comparison between normal and IUGR births. Mol Reprod Dev 49:229-235
11. Sheikh S, Satoskar P, Bhartiya D 2001 Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol Hum Reprod 7:287-292
12. Holmes R, Porter H, Newcomb P, Holly JM, Soothill P 1999 An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses. Placenta 20:325-330
13. Reid GJ, Flozak AS, Simmons RA 2002 Placental expression of insulin-like growth factor receptor-1 and insulin receptor in the growth-restricted fetal rat. J Soc Gynecol Invest 9:210-214
14. Nicolini U, Todros T, Ferrazzi E, Zorzoli A, Groli C, Zucca S, Tinti A, Dodero D, Destro F, Ceccarello P, et al 1986 Transverse fetal growth curves. A multicenter study. Minerva Ginecol 38:873-887
15. Arduini D, Rizzo G, Mancuso S, Romanini C 1987 Longitudinal assessment of blood flow velocity waveforms in the healthy human fetus. Prenat Diagn 7:613-617
16. Parazzini F, Cortinovis I, Bortolus R, Fedele L 1991 Standards of birth weight in Italy. Ann Ostet Ginecol Med Perinat 112:203-246
17. Virkamaki A, Ueki K, Kahn CR 1999 Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943
18. Giorgetti S, Pelicci PG, Pelicci G, Van Obberghen E 1994 Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur J Biochem 223:195-202
19. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
20. Barr RK, Bogoyevitch MA 2001 The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 33: 1047-1063
21. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
22. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
23. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367
24. Araki E, Lipes MA, Patti ME, Bruning JC, Haag III B, Johnson RS, Kahn CR 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190
25. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furata Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S 1994 Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186
26. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF 1999 IRS-2 coordinates IGF-1 receptor-mediated β-cell development and peripheral insulin signalling. Nat Genet 23:32-40
27. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ 2001 Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349-38352
28. Bauer MK, Breier BB, Bloomfield FH, Jensen EC, Gluckman PD, Harding JE 2003 Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth. J Endocrinol 177:83-92
29. Woodall SM, Breier BH, Johnston BM, Bassett NS, Barnard R, Gluckman PD 1999 Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring. J Endocrinol 163:69-77
30. Giorgino F, Logoluso F, Davalli AM, Napoli R, Laviola L, Hirshman MF, Horton ES, Weir GC, Smith RJ 1999 Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozotocin-induced diabetic rats. Diabetes 48:801-812
31. Laviola L, Belsanti G, Davalli AM, Napoli R, Perrini S, Weir GC, Giorgino R, Giorgino F 2001 Effects of streptozotocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes 50:2709-2720
32. Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U 1997 Insulin receptor substrate (IRS)-1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 94:4171-4175
33. Schuppin GT, Pons S, Hugl S, Aiello LP, King GL, White M, Rhodes CJ 1998 A specific increased expression of insulin receptor substrate 2 in pancreatic β-cell lines is involved in mediating serum-stimulated β-cell growth. Diabetes 47:1074-1085
34. Kornmann M, Maruyama H, Bergmann U, Tangvoranuntakul P, Beger HG, White MF, Korc M 1998 Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res 58:4250-4254
35. 1152→Gln insulin receptor. J Biol Chem 274:3094-3102
36. Fasshauer M, Klein J, Ueki K, Kriauciunas KM, Benito M, White MF, Kahn CR 2000 Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 275:25494-25501
37. Chibalin AV, Yu M, Ryder JW, Song XM, Galuska D, Krook A, Wallberg-Henriksson H, Zierath JR 2000 Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Proc Natl Acad Sci USA 97:38-43
38. Bruning JC, Winnay J, Cheatham B, Kahn CR 1997 Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 17:1513-1521
39. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
40. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD 1991 Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019-1022
41. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C 1994 Thinness at birth and insulin resistance in adult life. Diabetologia 37:150-154
42. Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ 2002 Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-α or EGF, augments pancreatic β-cell proliferation. Diabetes 51:966-976
43. Vuguin P, Raab E, Liu B, Barzilai N, Simmons R 2004 Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Diabetes 53:2617-2622
44. Levy R, Nelson DM 2000 To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 21:1-13
45. Smith SC, Baker PN, Symonds EM 1997 Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 177:57-65
46. Maruo T, Ishihara N, Samoto T, Murakoshi H, Laoag-Fernandez JB, Matsuo H 2001 Regulation of human trophoblast proliferation and apoptosis during pregnancy. Early Pregnancy 5:28-29
47. Smith SC, Baker PN, Symonds EM 1997 Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 177:1395-1401
48. Crocker IP, Cooper S, Ong SC, Baker PN 2003 Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 162:637-643
49. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ 1994 Cytotoxicity of tumour necrosis factor-α and γ-interferon against primary human placental trophoblasts. Placenta 15:819-835
50. Prinz W, Schuhmann RA, Kalbfleisch W 1983 Morphologic findings in the placenta in intrauterine fetal growth retardation. Zentralbl Gynakol 105:279-286
51. Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, Sadovsky Y, Nelson DM 2002 Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 186:1056-1061
52. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T 2002 Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186:158-166
53. Chi MM, Schlein AL, Moley KH 2000 High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouseblastocyst via down-regulation of the IGF-1 receptor. Endocrinology 141:4784-4792
54. Whitmarsh AJ, Davis RJ 2000 A central control for cell growth. Nature 403: 255-256
55. Ballif BA, Blenis J 2001 Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12:397-408
56. Saba-El-Leil MK, Vella FD, Vernay B, Voisin L, Chen L, Labrecque N, Ang SL, Meloche S 2003 An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4:964-968
57. Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannette L, Charron J 1999 Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9:369-372
58. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM 2000 Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97:10454-10459
59. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR 2000 Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116
60. Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF 1999 Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 89:115-124
61. Desai J, Holt-Shore V, Tony RJ, Caudle MR, Tony DS 1999 Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 1999 60:887-892
62. Hannke-Lohmann A, Pildner von Steinburg S, Dehne K, Benard V, Kolben M, Schmitt M, Lengyel E 2000 Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia. Obstet Gynecol 96:582-587
63. Schorpp-Kistner M, Wang ZQ, Angel P, Wagner EF 1999 JunB is essential for mammalian placentation. EMBO J 18:934-948